Impel Pharmaceuticals OverviewImpel Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for IMPL.
Quarterly Other Income/Expense
-$1.00M
As of Sep 30, 2023
Annual Other Income/Expense (TTM)
$3.65M
Trailing 12 months ending Sep 30, 2023